Status:
UNKNOWN
CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapy
Lead Sponsor:
Yonsei University
Conditions:
Colorectal Cancer
Lung Metastases
Eligibility:
All Genders
19+ years
Brief Summary
The investigators will detect circulating tumor DNA in blood of patients with lung metastases from colorectal cancer using NGS technology and intend to use it for predicting the outcome of local treat...
Detailed Description
The investigators produce customized gene target panel by selecting genes that are commonly found in colorectal cancer and metastasis from existing literature. In patients diagnosed with lung metasta...
Eligibility Criteria
Inclusion
- adults over 19 years of age
- those who understand research and have written consent
- cases diagnosed with lung metastases from colorectal cancer
Exclusion
- pregnant women, nursing women
- those who lack the ability to voluntarily agree
- participation in other clinical trials where drugs for clinical trials are administered within the past four weeks as of the date of participation in clinical trials
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04704960
Start Date
February 1 2021
End Date
December 1 2023
Last Update
January 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Laboratory Medicine, Yonsei University College of Medicine
Seoul, South Korea